AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rolston, K V
Right arrow Articles by Bodey, G P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rolston, K V
Right arrow Articles by Bodey, G P

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1987 April; 31(4): 650-652

In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancer.

K V Rolston, B LeBlanc, D H Ho and G P Bodey

ABSTRACT

The in vitro activity of paldimycin, a novel antimicrobial agent, was compared with that of vancomycin against 306 gram-positive isolates (representing 12 bacterial species) obtained from patients with cancer. Paldimycin had lower MICs for 90% of isolates than vancomycin did against most isolates tested. Its activity, however, was medium and pH dependent, being greatest in Nutrient broth at a pH of 6.8.

Antimicrob Agents Chemother. 1987 April; 31(4): 650-652






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 1987 by the American Society for Microbiology. All rights reserved.